Job Title
Sr. Director, Business Development (Safety Tox)
Industry Sector
Preclinical/Safety Toxicology
Location / Territory
West Coast
Salary Range
$150,000-$170,000
Total Compensation
$300,000 - $400,000
Company Size
2,000
Position Id
201803
Position Summary

Business Development Director – Preclinical Toxicology

Territory: West Coast

About the Company

This organization is a fast-growing, full-service drug development partner supporting biotechnology and pharmaceutical innovators worldwide. With approximately 2,000 employees across North America and the Asia-Pacific region, the company generates over $500 million in annual revenue, including more than $200 million from its preclinical toxicology division.

Through an integrated suite of services—ranging from discovery and safety testing through clinical and manufacturing support—the company enables clients to reach critical decision milestones faster and more efficiently. Their preclinical division is among the largest independent providers of non-clinical drug safety testing in North America, serving clients from early research through IND-enabling programs.

Position Overview

The Director of Business Development, Preclinical Toxicology will drive growth within an established, high-performing division recognized for rapid execution and strong repeat client relationships.
This individual will be responsible for developing new business and expanding existing client partnerships across a defined territory, representing a portfolio that includes GLP and non-GLP toxicology, discovery studies, bioanalysis, and IND-enabling services.

The role offers access to a substantial existing book of business, a respected scientific delivery team, and modern facilities with diverse species capabilities. The position reports to the Vice President of Business Development for the Preclinical division and functions as part of a national commercial organization of approximately 40 business developers.

Key Responsibilities

  • Drive growth through consultative selling and new client acquisition across assigned biopharma accounts.

  • Manage and expand relationships with existing clients, ensuring continuity and retention of repeat business (currently exceeding 80%).

  • Collaborate with scientific and operational teams to scope, price, and close complex preclinical programs.

  • Monitor competitive trends, pricing dynamics, and market share movements within the preclinical drug safety sector.

  • Represent the company at regional and national industry meetings to build brand visibility and client engagement.

  • Meet or exceed annual revenue and booking goals, with quarterly milestones and incentives for outperformance.

Company & Opportunity Differentiators

  • Market Position: A leading integrated CRO/CDMO platform approaching the top tier of preclinical safety testing providers in North America.

  • Growth Trajectory: The preclinical division is projected to exceed $250 million in revenue within the next year, with ongoing investment and capacity expansion.

  • Client Retention: Over 85% repeat business, driven by scientific excellence and consistent on-time delivery.

  • Decision Velocity: Agile, data-driven leadership that encourages autonomy and rapid execution—ideal for self-starters who thrive in fast-moving environments.

  • Earning Potential: Among the most competitive commission structures in the industry, where top performers routinely double their base compensation, with total earnings between $300K–$400K+.

  • Culture: Entrepreneurial, collaborative, and accountable—balancing scientific rigor with commercial agility.